Article
Patients with Beh}et's disease can find rapid relief from vision-threateninginflammation
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Beacon Therapeutics exercises option to license Abeona Therapeutics’ AAV204 capsid
3 Things You Should Know About Interventional Glaucoma Comanagement
RetinalGenix Technologies and LabCorp partner on DNA/RNA/GPS Pharmaco-Genetic Mapping platform
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Yale researchers identify corneal ulcer pathogens by testing tears
Health Canada approves Biocon's Yesafili, biosimilar to Eylea